Law: Sherman Antitrust Act 1890 (USA)

Google encouraged its employees to hold sensitive discussions via internal messages that were automatically deleted every day and misled the government about doing so, the Department of Justice has said in a request for sanctions against the company.

24 February 2023

McDonald’s justification for imposing no-poach provisions on franchisees in 1955 is irrelevant to whether those agreements are necessary for the 21st Century, two former employees have argued.

23 February 2023

A group of companies accusing Google of cornering off the market for digital mapping products have failed to correct the errors that saw their original complaint rejected, the defendant has argued.

22 February 2023

Google’s request for summary judgment in two monopolisation lawsuits brought by the Department of Justice and 47 US states ignores both precedent and evidence suggesting that its conduct forecloses 50% of the market for online search, the enforcers have said.

21 February 2023

A former engineering executive has asked a federal appellate court to throw out his bid-rigging conviction because the lower court improperly told a jury to analyse the case as a per se violation of the Sherman Act.

17 February 2023

The American Red Cross illegally tied the sale of blood platelets to a service that removes bacteria from the cells intended for transfusion, a medical products company has said.

16 February 2023

A group of farmers do not need evidence of deception to allege that John Deere illegally conspired to corner off the market for repairing its machinery, the Department of Justice has argued.

15 February 2023

Amgen should face allegations it illegally monopolised the market for a type of cholesterol drug through anticompetitive rebates, a federal magistrate judge has said.

14 February 2023

A group of aerospace engineers do not need to define a relevant antitrust market to prove Raytheon and Pratt & Whitney engaged in a per se violation of US antitrust law, the Department of Justice has argued.

14 February 2023

The Senate Judiciary Committee has advanced five bipartisan bills aiming to promote competition and reduce drug prices in the pharmaceutical industry.

13 February 2023